DAVID SALOFF

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2011-07-14 Our Board has determined that each of Messrs. Thomas W. Hoog, Kenneth Eaton, Anshuman “Andy” Dube and David Saloff is an independent director as defined in The Nasdaq Stock Market listing standards. David Saloff was appointed to our Board of Directors on June 30, 2011. Mr. Saloff is currently the Chief Executive Officer of Age Reversal, Inc., a position he has held since September 2010.

Data sourced from SEC filings. Last updated: 2025-08-30